Tourmaline Bio Inc.

NASDAQ: TRML
Share price (8/15/25): $22.57
Market cap (8/15/25): $580 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

QVT Financial LP

Avoro Capital Advisors LLC

Thiara Parvinder

Srivastava Sapna

News Filter

Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Investor Presentation

Shareholder Vote Results

– Rapid, Deep, and Durable Reductions in High-Sensitivity C-Reactive Protein (Hs-Crp) Through Day 90 Achieved Across All Pacibekitug Arms With High Statistical Significance as Compared to Placebo (P<0.0001 for All Arms) –

Reports First Quarter 2025 Financial Results and Recent Business Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission